Sparrow Cancer Center — Lansing, Michigan

Sparrow Cancer Center is a clinical research site located in Lansing, Michigan, United States 48912.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Sparrow Cancer Center has participated in 9 clinical trials with 2 currently active.

Therapeutic areas: Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma.

Sponsors: Celldex Therapeutics, Michigan State University, Agendia.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sparrow Cancer Center?

Sparrow Cancer Center has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sparrow Cancer Center conducted?

Sparrow Cancer Center has 9 clinical trials on record, with 2 currently active. Their work covers Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma.

Is Sparrow Cancer Center accredited by Crixeo Health?

Yes — Sparrow Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Sparrow Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.